NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
May 08 04:00PM ET
59.82
Dollar change
+0.50
Percentage change
0.84
%
Index- P/E22.20 EPS (ttm)2.69 Insider Own1.36% Shs Outstand191.76M Perf Week-4.61%
Market Cap11.47B Forward P/E13.78 EPS next Y4.34 Insider Trans-0.58% Shs Float189.18M Perf Month7.03%
Income523.88M PEG0.67 EPS next Q0.84 Inst Own96.99% Short Float2.68% Perf Quarter-7.03%
Sales2.92B P/S3.93 EPS this Y57.25% Inst Trans-0.84% Short Ratio2.98 Perf Half Y-9.38%
Book/sh30.21 P/B1.98 EPS next Y24.93% ROA7.47% Short Interest5.08M Perf Year-27.14%
Cash/sh6.63 P/C9.02 EPS next 5Y33.00% ROE9.64% 52W Range52.93 - 94.85 Perf YTD-8.99%
Dividend Est.- P/FCF18.38 EPS past 5Y- ROI8.20% 52W High-36.93% Beta0.23
Dividend TTM- Quick Ratio3.49 Sales past 5Y11.18% Gross Margin78.25% 52W Low13.02% ATR (14)2.28
Dividend Ex-Date- Current Ratio5.52 EPS Y/Y TTM152.10% Oper. Margin21.44% RSI (14)40.34 Volatility4.08% 3.88%
Employees3040 Debt/Eq0.11 Sales Y/Y TTM17.99% Profit Margin17.93% Recom1.52 Target Price96.92
Option/ShortYes / Yes LT Debt/Eq0.10 EPS Q/Q108.02% Payout0.00% Rel Volume0.86 Prev Close59.32
Sales Surprise0.88% EPS Surprise39.21% Sales Q/Q12.72% EarningsMay 01 AMC Avg Volume1.70M Price59.82
SMA20-1.49% SMA50-9.08% SMA200-15.00% Trades Volume1,465,951 Change0.84%
Date Action Analyst Rating Change Price Target Change
Feb-24-25Upgrade Oppenheimer Perform → Outperform $98
Nov-15-24Initiated Wolfe Research Outperform $95
Oct-30-24Downgrade William Blair Outperform → Mkt Perform
Oct-10-24Resumed Raymond James Outperform $79
Aug-20-24Upgrade Bernstein Mkt Perform → Outperform $94 → $110
May-17-24Downgrade Robert W. Baird Outperform → Neutral $104 → $72
May-14-24Initiated Evercore ISI Outperform $113
Nov-15-23Initiated Wells Fargo Overweight $100
Oct-23-23Upgrade Bernstein Underperform → Mkt Perform $82
Sep-28-23Initiated Raymond James Mkt Perform
May-07-25 04:11PM
May-06-25 09:45AM
May-05-25 09:50AM
May-02-25 05:57PM
01:23PM
08:13AM Loading…
08:13AM
03:16AM
May-01-25 07:30PM
07:25PM
05:15PM
04:17PM
04:05PM
Apr-29-25 11:38AM
Apr-27-25 01:13PM
Apr-23-25 08:47PM
09:40AM Loading…
09:40AM
08:44AM
Apr-21-25 10:16AM
Apr-18-25 09:45AM
Apr-17-25 10:00AM
09:00AM
Apr-16-25 10:00AM
09:53AM
Apr-11-25 03:06AM
Apr-10-25 12:10PM
08:17AM
02:37AM
Apr-09-25 03:00PM
Apr-08-25 09:56AM
Apr-07-25 01:22PM
12:45PM Loading…
12:45PM
12:00PM
11:40AM
09:40AM
Apr-03-25 03:37PM
10:14AM
04:54AM
Apr-02-25 03:06PM
09:48AM
09:45AM
09:00AM
Mar-28-25 09:50AM
Mar-27-25 10:10AM
05:06AM
Mar-26-25 05:11AM
Mar-25-25 09:18PM
Mar-21-25 11:30AM
10:10AM
05:05AM
Mar-20-25 03:25PM
09:00AM
Mar-19-25 05:05AM
Mar-18-25 05:55AM
Mar-17-25 09:45AM
Mar-12-25 12:45PM
09:55AM
09:50AM
Mar-11-25 09:01AM
05:03AM
Mar-05-25 09:40AM
Mar-04-25 04:03AM
Feb-28-25 09:45AM
Feb-25-25 09:00AM
08:03AM
08:03AM
Feb-24-25 04:05PM
12:45PM
10:24AM
09:55AM
09:37AM
Feb-21-25 09:25AM
06:00AM
Feb-20-25 05:56PM
02:42PM
01:50PM
09:39AM
07:30AM
02:11AM
Feb-19-25 05:30PM
05:20PM
04:32PM
04:21PM
04:05PM
Feb-18-25 08:06AM
Feb-13-25 09:15AM
Feb-12-25 10:00AM
Feb-08-25 08:58AM
Feb-05-25 12:45PM
09:00AM
Feb-04-25 10:01AM
Jan-27-25 03:04PM
09:45AM
Jan-23-25 06:45AM
Jan-20-25 09:57PM
12:45PM
Jan-13-25 12:00PM
09:55AM
09:40AM
Jan-09-25 09:45AM
Jan-06-25 08:30AM
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hubbard CristinEVP, Chief Commercial OfficerMay 02 '25Sale64.9227317,72332,700May 06 05:07 PM
Hubbard CristinOfficerMay 02 '25Proposed Sale64.9227317,723May 02 10:05 AM
Burkhart ErinGVP, Chief Accounting OfficerMar 19 '25Sale71.521,29592,61816,955Mar 20 07:38 PM
Burkhart ErinOfficerMar 19 '25Proposed Sale71.521,29592,618Mar 19 09:36 AM
Guyer Charles GregEVP, Chief Technical OfficerMar 06 '25Sale71.287,034501,35587,655Mar 07 04:06 PM
Guyer Charles GregOfficerMar 06 '25Proposed Sale71.287,034501,359Mar 06 04:05 PM
Burkhart ErinGVP, Chief Accounting OfficerFeb 24 '25Sale68.381,34491,90313,105Feb 25 08:21 PM
Burkhart ErinOfficerFeb 24 '25Proposed Sale68.381,34491,903Feb 24 10:26 AM
Guyer Charles GregEVP, Chief Technical OfficerNov 12 '24Sale66.375,278350,32468,909Nov 14 02:44 PM
Guyer Charles GregOfficerNov 12 '24Proposed Sale66.375,278350,324Nov 12 02:27 PM
Burkhart ErinGVP, Chief Accounting OfficerAug 13 '24Sale90.0071464,26014,449Aug 15 03:57 PM
Burkhart ErinOfficerAug 13 '24Proposed Sale90.0071464,260Aug 13 11:48 AM
HERON ELAINE JDirectorJun 03 '24Option Exercise63.105,047318,466101,888Jun 04 07:29 PM
MEIER RICHARD ADirectorJun 03 '24Option Exercise63.106,600416,460126,227Jun 04 07:28 PM
Mueller BrianEVP, Chief Financial OfficerMay 30 '24Option Exercise63.105,000315,50077,159May 31 06:28 PM
Mueller BrianEVP, Chief Financial OfficerMay 30 '24Sale75.195,000375,95072,159May 31 06:28 PM
Davis George EricEVP, Chief Legal OfficerMay 28 '24Option Exercise63.1040,8502,577,63597,007May 30 06:18 PM
Davis George EricEVP, Chief Legal OfficerMay 28 '24Sale74.5140,8503,043,80256,157May 30 06:18 PM
BIENAIME JEAN JACQUESDirectorMay 10 '24Option Exercise63.1020,0001,262,000494,994May 13 03:57 PM
BIENAIME JEAN JACQUESDirectorMay 10 '24Sale81.1420,0001,622,800474,994May 13 03:57 PM